Cell Point (India) (NSE:CELLPOINT) Equity-to-Asset: 0.44 (As of Mar. 2026) — 110% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CELLPOINT Cell Point (India) Ltd NSE:CELLPOINT
75 GF Score
Price ₹16.70
GF Value ₹35.16
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Cell Point (India) Equity-to-Asset?

Cell Point (India) NSE:CELLPOINT +4.38% 75 Equity-to-Asset is 0.44 as of Mar. 2026, which is 110% above its 10-year median of 0.21. GuruFocus rates NSE:CELLPOINT with a GF Score™ of 75/100 and a GF Value™ of ₹35.16 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 1,138 Retail - Cyclical companies, Cell Point (India) ranks better than 50.97% on this metric.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cell Point (India)'s Total Stockholders Equity for the quarter that ended in Mar. 2026 was ₹743 Mil. Cell Point (India)'s Total Assets for the quarter that ended in Mar. 2026 was ₹1,691 Mil. Therefore, Cell Point (India)'s Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.44.

The historical rank and industry rank for Cell Point (India)'s Equity-to-Asset or its related term are showing as below:

NSE:CELLPOINT' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.16   Med: 0.21   Max: 0.54
Current: 0.44

During the past 7 years, the highest Equity to Asset Ratio of Cell Point (India) was 0.54. The lowest was 0.16. And the median was 0.21.

NSE:CELLPOINT's Equity-to-Asset is ranked better than
50.97% of 1138 companies
in the Retail - Cyclical industry
Industry Median: 0.44 vs NSE:CELLPOINT: 0.44

Cell Point (India)  (NSE:CELLPOINT) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Cell Point (India) Equity-to-Asset Related Terms


Cell Point (India) Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Cell Point (India)'s Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Point (India) Equity-to-Asset Chart

Cell Point (India) Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Equity-to-Asset
Get a 7-Day Free Trial 0.16 0.21 0.54 0.54 0.44

Cell Point (India) Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.54 0.00 0.54 0.46 0.44

NSE:CELLPOINT vs CASY, WSM, ULTA: Equity-to-Asset Comparison

For the Specialty Retail subindustry, Cell Point (India)'s Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cell Point (India) Equity-to-Asset vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Cell Point (India)'s Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cell Point (India)'s Equity-to-Asset falls into.


NSE:CELLPOINT
75GF Score
Cell Point (India) Ltd NSE:CELLPOINT
Equity-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cell Point (India) Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cell Point (India)'s Equity to Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Equity to Asset (A: Mar. 2026 )=Total Stockholders Equity/Total Assets
=743.174/1691.05
=0.44

Cell Point (India)'s Equity to Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

Equity to Asset (Q: Mar. 2026 )=Total Stockholders Equity/Total Assets
=743.174/1691.05
=0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of 0.44 mean?
Cell Point (India) (NSE:CELLPOINT) has a Equity-to-Asset of 0.44 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cell Point (India) and its competitors. This is 110% above median its historical median of 0.21. Over the past decade, Cell Point (India)'s Equity-to-Asset has ranged from 0.16 to 0.54. According to the industry distribution chart, Cell Point (India) ranks #558 out of 1138 companies in the Retail - Cyclical industry, placing it in the top 49%.
Is Cell Point (India)'s Equity-to-Asset too high?
Cell Point (India)'s current Equity-to-Asset of 0.44 is 110% above median its 10-year median of 0.21. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 0.54. The Retail - Cyclical industry median Equity-to-Asset is 0.44. Cell Point (India)'s value of 0.44 is 0% at this industry median. Based on the distribution chart, Cell Point (India) ranks #558 out of 1138 companies in the Retail - Cyclical industry, which is above the industry midpoint. Overall, Cell Point (India) has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cell Point (India)'s Equity-to-Asset compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Cell Point (India) ranks #558 out of 1138 companies for Equity-to-Asset. This puts Cell Point (India) in the upper half of its industry. The industry median Equity-to-Asset is 0.44. Cell Point (India)'s value of 0.44 is 0% at this benchmark. Historically, Cell Point (India)'s own Equity-to-Asset has ranged from 0.16 to 0.54 over the past decade. While the company's 10-year median is 0.21 vs. the industry median of 0.44, Cell Point (India) has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Retail - Cyclical company?
The median Equity-to-Asset among Retail - Cyclical companies is 0.44, based on 1,138 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cell Point (India)'s current Equity-to-Asset of 0.44 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cell Point (India) and its competitors. For the Retail - Cyclical industry, the median Equity-to-Asset is 0.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Point (India)'s current Equity-to-Asset is 0.44, which is 110% above median its own 10-year median of 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Point (India) stock overvalued right now?
Based on GuruFocus' analysis, Cell Point (India) (NSE:CELLPOINT) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹35.16, compared to a current price of ₹16.70 — trading 52.5% below its estimated fair value. The current Equity-to-Asset is 0.44, which is 110% above median its 10-year median of 0.21 and 0% at the Retail - Cyclical industry median of 0.44. Cell Point (India)'s overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Cell Point (India) (NSE:CELLPOINT), the current Equity-to-Asset is 0.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cell Point (India) (NSE:CELLPOINT) Overvalued in 2026?

Based on GuruFocus' analysis, Cell Point (India) stock appears to be undervalued. The current stock price of ₹16.70 is trading 52.5% below its estimated GF Value™ of ₹35.16. GuruFocus considers Cell Point (India) to be Significantly Undervalued.

Key valuation signals for NSE:CELLPOINT:

  • Equity-to-Asset: 0.44 (110% above median its 10-year median of 0.21)
  • GF Value™: ₹35.16 vs. price of ₹16.70 (52.5% below fair value)
  • GF Score™: 75/100 with 6 warning signs
  • Industry Position: 0% at the Retail - Cyclical median (#558 of 1138)

No single metric tells the full story. See the NSE:CELLPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cell Point (India) Business Description

Address Lalitha Colony, Door No. 30-15-134, Dabagardens, Visakhapatnam, AP, IND, 530020
Cell Point (India) Ltd is engaged in multi-brand retail selling of smartphones, tablets, mobile accessories, and mobile-related products of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, etc. It is also engaged in retail selling of consumer durable electronics goods, smart televisions, smart watches, and air conditioners of various brands such as Xiaomi, Realme, and One Plus among others. The company operates in a single segment and derives revenue from its operations in India.
75GF Score

Get the complete analysis for NSE:CELLPOINT

Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹16.70
Price
₹35.16
GF Value